Dermatitis, Eczematous Completed Phase 3 Trials for Desloratadine (DB00967)

Also known as: Eczema / Eczema NOS / Eczematous rash / Dermatitis eczematoid / Eczematous dermatitis

IndicationStatusPhase
DBCOND0057011 (Dermatitis, Eczematous)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01916980Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Eczema/Dermatitis and Dermal Pruritus (MK-4117-202)Treatment